Referência |
Doença |
---|---|
SEQ1116 | Smith-Lemli-Opitz syndrome |
EXN1181 | Diaphragmatic hernia |
SEQ1097 | Joubert syndrome |
SEQ1101 | Hermansky-Pudlak syndrome |
SEQ9703 | Emphysema secondary to AAT (alpha-1-antitrypsin) deficiency, S and Z variants SERPINA1 (PiS (Glu264Val): rs17580 and PiZ (Glu342Lys): rs28929474) |
SEQ8331 | Pitt-Hopkins syndrome |
SEQ8281 | Peutz-Jeghers syndrome |
SEQ7771 | Opitz syndrome |
SEQ7511 | Nijmegen syndrome |
SEQ7512 | Nijmegen syndrome |
SEQ7104 | Marfan syndrome |
SEQ7105 | Marshall-Smith syndrome |
SEQ7102 | Marfan syndrome |
SEQ6508 | Joubert syndrome type 8 |
SEQ6509 | Joubert syndrome type 9 |
SEQ6303 | Joubert syndrome type 1 |
SEQ6502 | Joubert syndrome type 2 |
SEQ6504 | Joubert syndrome type 4 |
SEQ6505 | Joubert syndrome type 5 |
SEQ6506 | Joubert syndrome type 6 |
SEQ6301 | Joubert syndrome type 10 |
SEQ6302 | Joubert Syndrome Type 12 |
SEQ5981 | Hydroletal Syndrome |
SEQ5982 | Hyper IgE |
SEQ5965 | Hemochromatosis |
SEQ5926 | Hermansky-Pudlak syndrome |
SEQ5927 | Hermansky-Pudlak syndrome |
SEQ5928 | Hermansky-Pudlak syndrome |
SEQ5929 | Hermansky-Pudlak syndrome |
SEQ5930 | Hermansky-Pudlak syndrome |
SEQ5921 | Hermansky-Pudlak syndrome type 2 |
SEQ5922 | Hermansky-Pudlak syndrome |
SEQ5924 | Hermansky-Pudlak syndrome |
SEQ5925 | Hermansky-Pudlak syndrome |
SEQ5741 | Gorlin syndrome |
SEQ5742 | Gorlin syndrome |
SEQ5743 | Chronic Granulomatous Disease |
SEQ5671 | GAPO syndrome |
SEQ5405 | Cystic Fibrosis and Differential Diagnosis |
SEQ5400 | Cystic Fibrosis, 50 most frequent CFTR gene mutations |
SEQ5401 | Cystic fibrosis |
SEQ5402 | Cystic fibrosis |
SEQ5265 | Tuberous sclerosis |
SEQ5266 | Tuberous sclerosis |
SEQ5267 | Tuberous sclerosis |
SEQ5071 | Pulmonary veno-occlusive disease |
SEQ5072 | Pulmonary veno-occlusive disease |
SEQ4851 | Ectrodactyly, Ectodermal Dysplasia and Palatal Cleft Syndrome type 3 (EEC Type 3) |
SEQ4021 | Brain demyelination due to methionine adenosyltransferase deficiency |
SEQ3872 | Pulmonary surfactant deficiency |
SEQ3873 | Pulmonary surfactant deficiency |
SEQ3875 | Pulmonary surfactant deficiency |
SEQ3876 | Pulmonary surfactant deficiency |
SEQ3841 | Mitochondrial trifunctional protein deficiency |
SEQ3731 | Fructose-1,6 diphosphatase deficiency |
SEQ3081 | Costello syndrome |
SEQ2841 | CHILD syndrome |
SEQ2361 | Bloom syndrome |
SEQ2311 | Síndrome de Birt-Hogg-Dube, mutaciones c.1285delC y c.1285dupC gen FLCN Birt-Hogg-Dube syndrome, c.1285delC and c.1285dupC mutations FLCN gene |
SEQ2312 | Birt-Hogg-Dube syndrome |
SEQ2011 | Kidney, interstitial, lung and joint autoimmune disease |
SEQ1973 | Spinal muscular atrophy with respiratory failure |
SEQ1771 | Antley-Bixler syndrome |
SEQ1781 | Apert syndrome, p.Ser252Trp and p.Pro253Arg mutations by FGFR2 gene sequencing |
SEQ1441 | Alexander disease |
SEQ1381 | X-linked agammaglobulinemia |
SEQ1291 | 2-hydroxyglutaric aciduria |
SEQ1301 | Fumaric aciduria, mutation c1431_1433dupAAA FH gene |
SEQ1261 | Methylmalonic acidemia with homocystinuria, type cbl F |
SEQ1255 | Methylmalonic acidemia |
SEQ1256 | Methylmalonic acidemia |
SEQ1252 | Methylmalonic acidemia |
SEQ1253 | Methylmalonic acidemia |
SEQ1254 | Methylmalonic acidemia |
SEQ1072 | DICER1 Syndrome |
SEQ1074 | Glow Syndrome (Tissue Mosaicism) |
SEQ1038 | Congenital Central Hypoventilation Syndrome |
MLP3401 | Hereditary hemorrhagic telangiectasia, Primary pulmonary hypertension |
MLP3315 | Smith-Lemli-Opitz, syndrome of |
MLP2961 | Peutz-Jeghers syndrome |
MLP2801 | Opitz syndrome |
MLP2541 | Marfan syndrome |
MLP2542 | Marfan syndrome |
MLP2151 | Hyper-IgE syndrome |
MLP2001 | Gorlin syndrome |
MLP2020 | Chronic granulomatous disease |
MLP1831 | Tuberous sclerosis 1 |
MLP1832 | Tuberous sclerosis 2 |
MLP1901 | Cystic fibrosis |
MLP1551 | CRI-DU-CHAT syndrome. |
MLP1231 | Birt-Hogg-Dube syndrome |
MLP1005 | X-linked Agammaglobulinemia |
EXN1167 | Lymphatic Malformations and Related Diseases |
EXN1110 | Hermansky‐Pudlak syndrome |
EXN1111 | Pulmonary hypertension |
EXN1105 | Congenital central hypoventilation syndrome |
EXN1047 | Hyperimmunoglobulin E syndrome |
As referências SEQ correspondem a estudos realizados utilizando o NIMSeq® | |
As referências EXN correspondem a estudos realizados com ExoNIM® |
Para a consulta dos genes associados a cada abordagem e do catálogo completo de serviços, dirija-se ao nosso motor de busca de estudos genéticos